Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
Anebulo Pharmaceuticals Inc
Total Assets
Anebulo Pharmaceuticals Inc
Total Assets Peer Comparison
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Anebulo Pharmaceuticals Inc
NASDAQ:ANEB
|
Total Assets
$11.7m
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Assets
$172B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Assets
$99B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
23%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Total Assets
$221.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
Merck & Co Inc
NYSE:MRK
|
Total Assets
$105.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
0%
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Assets
$63.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
See Also
What is Anebulo Pharmaceuticals Inc's Total Assets?
Total Assets
11.7m
USD
Based on the financial report for Jun 30, 2023, Anebulo Pharmaceuticals Inc's Total Assets amounts to 11.7m USD.
What is Anebulo Pharmaceuticals Inc's Total Assets growth rate?
Total Assets CAGR 3Y
57%
Over the last year, the Total Assets growth was -25%. The average annual Total Assets growth rates for Anebulo Pharmaceuticals Inc have been 57% over the past three years .